13/09/2025
Fetal polycystic kidney disease (PKD) is a genetic disorder where a fetus develops many fluid-filled cysts in its kidneys, leading to enlarged kidneys and poor kidney function even before birth. The two main types are autosomal recessive polycystic kidney disease (ARPKD), which is rare and requires both parents to pass the mutated gene, and autosomal dominant polycystic kidney disease (ADPKD). Fetal ARPKD can lead to severe breathing problems and is often detected during pregnancy via ultrasound due to the enlarged, bright kidneys on the scan. Early diagnosis allows for crucial monitoring, potential treatments, and support for the affected child and family, with outcomes varying based on the type and severity of the disease. Types and InheritanceAutosomal Recessive Polycystic Kidney Disease (ARPKD):This is a rare, severe genetic condition where both parents must carry and pass on a mutated gene for their child to have the disorder. Autosomal Dominant Polycystic Kidney Disease (ADPKD):While less common to diagnose prenatally, ADPKD is also a genetic form of the disease. Symptoms and DiagnosisFetal Characteristics:Fetal PKD is identified by enlarged kidneys with numerous small, fluid-filled cysts, which appear very bright on an ultrasound. Prenatal Signs:The disease may cause poor kidney function and a gradual reduction in amniotic fluid (oligohydramnios) during pregnancy. Ultrasound:Prenatal ultrasounds, often starting around 15 weeks of gestation, can detect the characteristic enlarged and bright kidneys. Complications and PrognosisRespiratory Problems:A significant complication in newborns with ARPKD is severe breathing difficulty due to underdeveloped lungs (pulmonary hypoplasia). Severity:The outcome of fetal PKD is generally guarded, and the earlier the onset of symptoms, the more severe the condition. Long-Term Outlook:Many babies with ARPKD may die from breathing difficulties shortly after birth, but those who survive the first month have a better chance of living into adulthood. Management and SupportMonitoring:Regular ultrasound examinations are used to monitor the severity of the disease during pregnancy. Treatment:While there is no cure for the underlying genetic condition, treatments focus on managing complications like hypertension and providing supportive care to improve quality of life and long-term outcomes. Family Care:Comprehensive family support, including early intervention and developmental monitoring, is essential for families affected by this chronic condition.
